Endocrinology

Top Story

Individualizing blood glucose goals cuts costs, improves quality of life

Individualizing blood glucose goals cuts costs, improves quality of life
December 11, 2017

An individualized approach to glucose control for adults with type 2 diabetes in the United States resulted in reduced costs and increased quality of life compared with uniform intensive control approaches, according to data published in Annals of Internal Medicine.

“To date, the clinical implications and economic value of individualizing glycemic goals have not been examined,” Neda Laiteerapong, MD, MS, FACP, assistant professor of general internal medicine in the department of medicine and associate director of the Center for Chronic Disease Research and Policy at the University of Chicago, and colleagues wrote. “It is highly unlikely that diabetes trials will be designed to compare the lifetime effects of individualized vs. uniform intensive glycemic control. Without these analyses, the need for policymakers to prioritize individualized diabetes care is uncertain.”

In the Journals

Impact of PCI vs. CABG on outcomes varies by acuity of presentation in diabetes

December 11, 2017
The mode of revascularization and acuity of presentation appear to affect short-term outcomes among patients with diabetes and multivessel disease, leading researchers…

FDA approves short-acting insulin Admelog for type 2 diabetes

December 11, 2017
The FDA on Monday announced the approval of Admelog, the first follow-on short-acting insulin indicated to improve blood glucose control in adult and pediatric patients…
In the Journals

Fatty liver index useful for predicting precancerous colon polyps

December 11, 2017
Patients with a high fatty liver index, a noninvasive method used to predict non-alcoholic fatty liver disease, showed a higher risk for colorectal adenomas, according…
In the Journals Plus

Survey: Physicians rate weight-loss medications, surgery less effective than lifestyle in obesity management

December 11, 2017
Primary care physicians and obesity medicine specialists rated behavioral factors as a greater cause of weight gain vs. biological factors, and rated weight-loss…
More Headlines »
CME CE

Innovations in Insulin: New Opportunities to Individualize Therapy

Presented by the Annenberg Center for Health Sciences.
This activity is supported by an independent educational grant from Novo Nordisk Inc.
This activity is supported by an educational grant from Lilly.

Vivian A. Fonseca, MD, and Jonathan D. Leffert, MD, combine their expertise and discuss emerging concepts, treatment…
More »
Video
Meeting News

VIDEO: ‘Dysmobility syndrome’ provides better understanding of fracture than osteoporosis alone

October 16, 2017
More »
Resource Centers
ObesityWeek

ObesityWeek

CME CNE CPE CE

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W…
More »
Current Issues
View the Current Issue